Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers
Clinical trial NCT05814809 · COMPLETED
Trial details
- NCT number
- NCT05814809
- Sponsor
- Onconic Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2022-10-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.